SEC Filings for Sorrento Therapeutics Inc. (SRNE)

$ 1.61   -0.06 (-3.59%) Volume: 1.52m 4:00 PM EST 12-Nov-2019
Filing Type:
Form TypeForm DescriptionPagesDateView
10-QGeneral form for quarterly reports under Section 13 or 15(d)711/12/2019
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans511/12/2019
8-KCurrent report pursuant to Section 13 or 15(d)510/09/2019
8-KCurrent report pursuant to Section 13 or 15(d)6310/08/2019
424B5Prospectus [Rule 424(b)(5)]5010/08/2019
424B5Prospectus [Rule 424(b)(5)]4010/01/2019
CT ORDERConfidential treatment order110/01/2019
8-KCurrent report pursuant to Section 13 or 15(d)1510/01/2019
8-KCurrent report pursuant to Section 13 or 15(d)4310/01/2019
SC 13GStatement of acquisition of beneficial ownership by individuals2309/25/2019
8-KCurrent report pursuant to Section 13 or 15(d)2509/23/2019
8-KCurrent report pursuant to Section 13 or 15(d)409/23/2019
DEF 14AOther definitive proxy statements208/14/2019
CT ORDERConfidential treatment order108/14/2019
8-KCurrent report pursuant to Section 13 or 15(d)308/12/2019
<<
First
<
Prev
123456789101112131415